BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.००८०
०.००%
(०.००) 1D
नोभेम्बर २३, १०:०७:५१ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
१.७७ करोड
Avg. vol.
१.१२ करोड
Volume
२.७३ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
१.७७ करोड
Avg. vol.
१.१२ करोड
Volume
२.७३ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Bloomberg.com
·
३३ मिनेट पहिले
Asia-Pacific Stocks Brace for Selloff After Wall Street Rout
Beinsure
·
३७ मिनेट पहिले
Nasdaq Composite record highs in 2026 raise concerns over AI stock valuations
Yahoo Finance
·
१ घण्टा पहिले
General Motors (GM) Joins The NASDAQ Composite, Is The Stock Still Undervalued?
cwibc.co.id
·
२ घण्टा पहिले
S&P 500 Faces Thanksgiving Week After Sharp Market Selloff
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd